Clinical Characteristics, Prognostic Factors and Therapeutic Strategies in Gastric Cancer Patients With Bone Metastasis: A Retrospective Analysis
Cancer Medicine · 2025
DOI: 10.1002/cam4.70781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Shiji Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Bone Neoplasms. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Jiangsu Provincial Natural Science Foundation Youth Project.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Bone metastases are highly refractory and are associated with extremely poor survival. Despite the increasing incidence of bone metastasis in gastric cancer (GC), comprehensive analyses regarding the clinicopathological features, prognosis, and treatment of bone‐metastatic GC remain limited.
Methods
We obtained data from 120 bone‐metastatic GC patients from Nanjing Drum Tower Hospital and 36,139 GC patients from the SEER database. Chi‐square and Mann–Whitney U ‐tests evaluated clinicopathological features, while Cox models identified prognostic factors. Kaplan–Meier curves and forest plots assessed the effects of different treatment strategies on overall survival after bone metastasis (OS‐BM).
Results
Among 120 bone‐metastatic GC patients, 55 (45.83%) were diagnosed with poorly cohesive gastric carcinoma (PCC). The higher incidence of bone metastasis was also observed in SRCC patients from the SEER database ( p < 0.0001). PCC patients exhibited distinct pathological features compared to non‐PCC patients, including lower PD‐L1 ( p = 0.042) and E‐cadherin expression ( p = 0.049). Multivariate analysis identified various negative prognostic factors such as metachronous bone metastasis ( p < 0.001, HR = 2.35, 95% CI:1.47–3.74) and CA125 expression ( p = 0.036, HR = 1.60, 95% CI:1.03–2.48), whereas immunotherapy was a positive prognostic factor ( p < 0.001, HR = 0.44, 95% CI:0.29–0.66). Subgroup analysis also showed improved survival among different populations of bone‐metastatic GC patients receiving immunotherapy. Moreover, combinational therapies including immunotherapy and other treatments (anti‐angiogenic therapy and/or local radiotherapy) further improved patient OS‐BM.
Conclusion
Our results suggest bone‐metastatic GC patients exhibit distinct clinicopathological features, with a high incidence of bone metastasis in PCC. Immunotherapy‐based combination therapies offer improved survival benefits, thus supporting the application of immunotherapy in GC patients at high risk of bone metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
- Nanjing Medical Key Laboratory of Oncology, Nanjing, China.
ORCID-Profile: Ju Yang, Baorui Liu, Jia Wei
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Jiangsu Provincial Natural Science Foundation Youth Project
- General Project of Nanjing Health Science and Technology Development Program
- Jiangsu Provincial Medical Key Discipline
Zitieren
APA
Ren, S., Wei, Y., Liu, W., Zhang, Y., Wang, Y., Yang, J., Liu, B., Shi, T., & Wei, J. (2025). Clinical Characteristics, Prognostic Factors and Therapeutic Strategies in Gastric Cancer Patients With Bone Metastasis: A Retrospective Analysis. Cancer Medicine. https://doi.org/10.1002/cam4.70781
Vancouver
Ren S, Wei Y, Liu W, Zhang Y, Wang Y, Yang J, et al. Clinical Characteristics, Prognostic Factors and Therapeutic Strategies in Gastric Cancer Patients With Bone Metastasis: A Retrospective Analysis. Cancer Medicine. 2025. doi:10.1002/cam4.70781
BibTeX
@article{Ren2025,
author = {Ren, Shiji and Wei, Yutao and Liu, Wenqi and Zhang, Yipeng and Wang, Yue and Yang, Ju and Liu, Baorui and Shi, Tao and Wei, Jia},
title = {Clinical Characteristics, Prognostic Factors and Therapeutic Strategies in Gastric Cancer Patients With Bone Metastasis: A Retrospective Analysis},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70781}
}
EUVIMED